U
Ute Bargfrieder
Researcher at University of Graz
Publications - 8
Citations - 694
Ute Bargfrieder is an academic researcher from University of Graz. The author has contributed to research in topics: Neoadjuvant therapy & Breast cancer. The author has an hindex of 4, co-authored 7 publications receiving 456 citations. Previous affiliations of Ute Bargfrieder include Medical University of Graz.
Papers
More filters
Journal ArticleDOI
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series.
Sigurd Lax,Kristijan Skok,Peter M. Zechner,Harald H. Kessler,Norbert Kaufmann,Camillo Koelblinger,Klaus Vander,Ute Bargfrieder,Michael Trauner +8 more
TL;DR: COVID-19 predominantly involves the lungs, causing DAD and leading to acute respiratory insufficiency and death may be caused by the thrombosis observed in segmental and subsegmental pulmonary arterial vessels despite the use of prophylactic anticoagulation.
Journal ArticleDOI
COVID-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center.
Kristijan Skok,Klaus Vander,Lisa Setaffy,Harald H. Kessler,Stephan W. Aberle,Ute Bargfrieder,Michael Trauner,Sigurd Lax +7 more
TL;DR: Systematic dissection and processing of the lungs revealed pulmonary infarction caused by thrombosis and thromboembolism and subsequent bacterial bronchopneumonia as the most frequent cause of death.
Journal ArticleDOI
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
Hannah Deborah Müller,Florian Posch,Christoph Suppan,Ute Bargfrieder,Melanie Gumpoldsberger,Robert Hammer,Hubert Hauser,Nadia Dandachi,Kurt Prein,Herbert Stoeger,Sigurd F. Lax,Marija Balic +11 more
TL;DR: The results confirm the RCB score as externally valid prognostic marker and being independent of molecular subtype for RFS and OS in a clinical setting in aclinical setting.
Journal ArticleDOI
Pulmonary Arterial Thrombosis Is a Novel and Underreported Feature in Severe COVID-19 with Fatal Outcome: Results from a Prospective Single-Centre Clinicopathological Case Series
Sigurd Lax,Kristijan Skok,Peter M. Zechner,Harald H. Kessler,Norbert Kaufmann,Camillo Koelblinger,Klaus Vander,Ute Bargfrieder,Michael Trauner +8 more
TL;DR: COVID-19 predominantly involves the lungs by causing DAD which leads to acute respiratory insufficiency and if overcome to pulmonary fibrosis and Rapid deterioration with fatal outcome may be caused by pulmonary arterial thrombosis frequently leading to pulmonary haemorrhage, infarction and subsequent bronchopneumonia.
Journal ArticleDOI
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Christoph Suppan,Florian Posch,Hannah Deborah Mueller,Nina Mischitz,Daniel Steiner,Eva Valentina Klocker,Lisa Setaffy,Ute Bargfrieder,Robert E. Hammer,Hubert Hauser,Philipp J. Jost,Philipp J. Jost,Nadia Dandachi,Sigurd Lax,Marija Balic +14 more
TL;DR: In this paper, the authors evaluated the prognostic value of residual cancer burden (RCB) scores in an extended validation cohort and analyzed the association between chemotherapy dose reduction and RCB scores.